Your browser is no longer supported. Please, upgrade your browser.
ABMD Abiomed, Inc. daily Stock Chart
Abiomed, Inc.
IndexS&P 500 P/E46.83 EPS (ttm)5.61 Insider Own1.60% Shs Outstand45.09M Perf Week-1.25%
Market Cap11.85B Forward P/E45.12 EPS next Y5.82 Insider Trans-9.83% Shs Float44.23M Perf Month2.46%
Income259.00M PEG1.64 EPS next Q0.97 Inst Own89.50% Short Float5.10% Perf Quarter4.49%
Sales769.40M P/S15.40 EPS this Y92.60% Inst Trans-0.06% Short Ratio3.25 Perf Half Y-18.93%
Book/sh20.78 P/B12.65 EPS next Y29.05% ROA27.90% Target Price336.88 Perf Year-38.51%
Cash/sh10.91 P/C24.10 EPS next 5Y28.50% ROE31.40% 52W Range228.00 - 459.75 Perf YTD-19.16%
Dividend- P/FCF56.91 EPS past 5Y99.70% ROI23.50% 52W High-42.85% Beta0.30
Dividend %- Quick Ratio5.60 Sales past 5Y33.20% Gross Margin83.20% 52W Low15.25% ATR7.82
Employees1371 Current Ratio6.40 Sales Q/Q18.80% Oper. Margin29.20% RSI (14)54.30 Volatility2.81% 2.82%
OptionableYes Debt/Eq0.00 EPS Q/Q104.20% Profit Margin33.70% Rel Volume0.43 Prev Close260.06
ShortableYes LT Debt/Eq0.00 EarningsAug 01 BMO Payout0.00% Avg Volume694.24K Price262.77
Recom1.30 SMA201.59% SMA500.91% SMA200-15.84% Volume310,911 Change1.04%
Nov-07-18Upgrade Morgan Stanley Equal-Weight → Overweight
Nov-02-18Upgrade BTIG Research Neutral → Buy
Jun-22-18Reiterated Piper Jaffray Overweight $360 → $480
Apr-04-18Initiated Goldman Buy $332
Jan-19-18Reiterated Leerink Partners Outperform $200 → $265
Oct-16-17Downgrade BTIG Research Buy → Neutral
Sep-29-17Initiated SunTrust Buy $195
Jun-08-17Resumed William Blair Outperform
Apr-06-17Upgrade Piper Jaffray Neutral → Overweight
Dec-07-16Initiated Guggenheim Buy
Oct-30-15Upgrade Raymond James Mkt Perform → Outperform
Aug-18-15Initiated Sterne Agee CRT Buy $130
Aug-12-15Reiterated The Benchmark Company Buy $96 → $129
Aug-05-15Reiterated Northland Capital Market Perform $60 → $80
Aug-04-15Reiterated The Benchmark Company Buy $89 → $96
May-06-15Reiterated Northland Capital Market Perform $40 → $60
May-06-15Reiterated Leerink Partners Outperform $72 → $88
Jan-28-15Upgrade Northland Capital Under Perform → Market Perform
Jan-10-14Reiterated Wunderlich Buy $29 → $35
Oct-08-13Upgrade The Benchmark Company Speculative Buy → Buy $25
Jul-18-19 07:41AM  A Closer Look At Abiomed, Inc.'s (NASDAQ:ABMD) Impressive ROE Simply Wall St.
Jul-13-19 07:26AM  Health care is one of the stock markets healthiest sectors right now MarketWatch
Jul-11-19 08:00AM  Abiomed First Quarter Fiscal 2020 Earnings and Conference Call Notification Business Wire
Jul-10-19 08:00AM  Are These Medical Stocks Cruising Toward Big Gains? Here's A Bullish Sign Investor's Business Daily
Jul-01-19 12:14PM  Here's What Abiomed, Inc.'s (NASDAQ:ABMD) ROCE Can Tell Us Simply Wall St.
12:11PM  Need To Know: Abiomed, Inc. (NASDAQ:ABMD) Insiders Have Been Selling Shares Simply Wall St.
Jun-29-19 08:00AM  3 Top Healthcare Stocks to Buy Motley Fool
Jun-27-19 08:42AM  New Strong Sell Stocks for June 27th Zacks
Jun-19-19 08:34AM  New Strong Sell Stocks for June 19th Zacks
Jun-18-19 09:30AM  IART vs. ABMD: Which Stock Should Value Investors Buy Now? Zacks
Jun-13-19 02:00PM  Impella Featured as an Innovative Technology at U.S. Capitol Event Showcasing Improvements to Womens Health Business Wire
09:46AM  Hedge Funds Have Never Been This Bullish On ABIOMED, Inc. (ABMD) Insider Monkey
Jun-07-19 09:58AM  Abiomed, Inc. (NASDAQ:ABMD): Will The Growth Last? Simply Wall St.
Jun-05-19 08:14AM  New Strong Sell Stocks for June 5th Zacks
Jun-04-19 03:33PM  Not Just Uber: 5 Stocks Analysts Love Unanimously Investor's Business Daily
Jun-01-19 09:31AM  Why Is Abiomed (ABMD) Up 0.6% Since Last Earnings Report? Zacks
May-31-19 05:45PM  Abiomed (ABMD) Dips More Than Broader Markets: What You Should Know Zacks
May-29-19 09:34AM  Abiomed to Present at Upcoming Investor Conferences Business Wire
May-23-19 05:48PM  Abiomed Inc (ABMD) Files 10-K for the Fiscal Year Ended on March 31, 2019
May-22-19 09:58AM  ABIOMED Gets FDA Confirmation of the Safety of Impella RP Zacks
06:05AM  FDA clears Abiomed heart pump after concerns over death rate American City Business Journals
May-21-19 05:51PM  Top 5 S&P 500 Stocks for 2018 by Performance Investopedia
12:42PM  FDA Confirms Impella RP is Safe and Effective; Only Right-Sided Device with FDA Approval Business Wire
12:15PM  National Cardiogenic Shock Initiative (NCSI) with Impella Best Practices Demonstrates 72% Survival with 98% Native Heart Recovery Business Wire
May-20-19 07:36AM  ABIOMED (ABMD) to Launch Impella CP With SmartAssist at SCAI Zacks
May-19-19 10:53AM  Top 5 Health Care Stocks of 2018 by Performance Investopedia
May-16-19 08:00AM  Impella SmartAssist Platform Launches at SCAI, Designed to Further Improve Patient Outcomes Business Wire
May-14-19 07:34AM  ABIOMED's Impella 5.0 and LD Receive Expanded FDA Approvals Zacks
May-13-19 12:00PM  FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy Business Wire
10:16AM  Is ABIOMED, Inc.'s (NASDAQ:ABMD) High P/E Ratio A Problem For Investors? Simply Wall St.
02:30AM  Abiomed and Intersect ENT Stumble to Start 2019 Motley Fool
May-10-19 04:14PM  ShockWave Medical's Revenue Soars in Its Public Debut Motley Fool
12:02PM  2 Winners and 2 Losers in the Med Tech Market This Quarter Motley Fool
May-07-19 03:33AM  Edited Transcript of ABMD earnings conference call or presentation 2-May-19 12:00pm GMT Thomson Reuters StreetEvents
May-02-19 05:31PM  ABIOMED Inc. (ABMD) Q4 2019 Earnings Call Transcript Motley Fool
04:46PM  Stocks book worst multiday losses in 5 weeks after Powell dampens Fed rate-cut hopes MarketWatch
04:32PM  Qualcomm and Tesla rise while Abiomed and Fluor fall Associated Press
04:09PM  Medtech CEO Promises To 'Correct The Course' As Shares Dive On Sales Lag Investor's Business Daily
03:35PM  Abiomed Comes Up Short as Growth Slows Motley Fool
10:41AM  Abiomed Shares Fall Following Revenue Miss and Poor Guidance
10:36AM  US STOCKS-Wall St inches higher with earnings in spotlight Reuters
09:14AM  US STOCKS-Wall St set for mixed open with earnings in spotlight Reuters
08:49AM  ABIOMED (ABMD) Q4 Earnings Meet Estimates, Sales Rise in Japan Zacks
08:25AM  Abiomed (ABMD) Matches Q4 Earnings Estimates Zacks
07:32AM  Abiomed: Fiscal 4Q Earnings Snapshot Associated Press
07:05AM  FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial Business Wire
07:00AM  Abiomed Announced Q4 FY 2019 Revenue of $207 Million and 31.6% Operating Margin Business Wire
06:00AM  ABIOMED, Inc. to Host Earnings Call ACCESSWIRE
May-01-19 10:00AM  Varian's (VAR) Halcyon to Treat Patients at Japan's Hospital Zacks
Apr-30-19 09:27AM  10 A-Rated Stocks the Smart Money Is Piling Into InvestorPlace
Apr-29-19 10:31AM  Will Flagship Impella Drive ABIOMED's (ABMD) Q4 Earnings? Zacks
Apr-27-19 06:00PM  3 Top Healthcare Stocks to Buy Right Now Motley Fool
Apr-25-19 05:45PM  Abiomed (ABMD) Dips More Than Broader Markets: What You Should Know Zacks
10:33AM  Abiomed (ABMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Apr-24-19 10:24AM  You can find plenty of solid stock bargains in this years worst-performing sector, analysts say MarketWatch
Apr-23-19 09:28AM  Clinical Data Highlights Advantages of Protected PCI to Enable Complete Revascularization and Improved Patient Quality of Life Business Wire
Apr-22-19 01:55PM  The ABIOMED (NASDAQ:ABMD) Share Price Is Up 939% And Shareholders Are Delighted Simply Wall St.
Apr-19-19 09:30AM  TMO or ABMD: Which Is the Better Value Stock Right Now? Zacks
09:15AM  Jim Cramer Weighs In On Campbell Soup, Funko, Marvell Technology And More Benzinga
Apr-18-19 05:45PM  Abiomed (ABMD) Outpaces Stock Market Gains: What You Should Know Zacks
Apr-12-19 05:45PM  Abiomed (ABMD) Stock Sinks As Market Gains: What You Should Know Zacks
10:10AM  Why Abiomed (ABMD) Could Beat Earnings Estimates Again Zacks
09:08AM  Will Instruments Drive Intuitive Surgical (ISRG) Q1 Earnings? Zacks
Apr-11-19 03:01PM  Abiomed Fourth Quarter Fiscal 2019 Earnings and Conference Call Notification Business Wire
12:23PM  5 Top Medical Device Stocks for 2019 Motley Fool
Apr-09-19 11:33AM  The Zacks Analyst Blog Highlights: Heidrick & Struggles International, ABIOMED, SeaWorld Entertainment, Darden Restaurants and AAON Zacks
11:11AM  Align Rides on Firm Global Footprint Despite Fierce Rivalry Zacks
Apr-08-19 09:47AM  Company News For Apr 8, 2019 Zacks
07:04AM  5 Top Stocks to Gain From Blowout Jobs Report Zacks
Apr-07-19 02:00PM  Why Abiomed Stock Fell 15% in March Motley Fool
Apr-05-19 10:18AM  Stock Market News For Apr 5, 2019 Zacks
09:03AM  ABIOMED Impella Data Show Significant Rise in Survival Rates Zacks
Apr-04-19 05:50PM  Abiomed (ABMD) Stock Sinks As Market Gains: What You Should Know Zacks
10:13AM  Varian Medical Opens Office in South Africa, Expands in EMEA Zacks
08:11AM  Cardiogenic Shock Survival Rates Improve Significantly in Three Years Since Impella FDA PMA Approval Business Wire
Apr-02-19 09:00AM  All You Need to Know About Abiomed (ABMD) Rating Upgrade to Buy Zacks
Apr-01-19 02:35PM  Why ABIOMED, Inc. (NASDAQ:ABMD) Is A Financially Healthy Company Simply Wall St.
10:58AM  Here's Why You Should Retain ABIOMED Stock in Your Portfolio Zacks
Mar-29-19 05:45PM  Abiomed (ABMD) Gains But Lags Market: What You Should Know Zacks
Mar-20-19 02:27PM  Abbott's (ABT) MitraClip COAPT Trial Shows Favorable Results (revised) Zacks
11:48AM  Here's Why You Should Retain Patterson Companies (PDCO) Stock Zacks
07:46AM  Abbott's (ABT) MitraClip COAPT Trial Shows Favorable Results (Revised) Zacks
Mar-19-19 05:50PM  Abiomed (ABMD) Gains As Market Dips: What You Should Know Zacks
12:21PM  Boston Scientific (BSX) Rides on Acquisitions, Innovation Zacks
12:19PM  Boston Scientific's EP Arm Gets a Lift From Study Success Zacks
11:42AM  Abbott's (ABT) MitraClip COAPT Trial Shows Favorable Results Zacks
10:56AM  Here's Why You Should Invest in Integer Holdings (ITGR) Stock Zacks
09:35AM  HealthEquity (HQY) Earnings & Revenues Beat Estimates in Q4 Zacks
Mar-18-19 11:17AM  Allscripts Partners With Opargo to Boost Practice Management Zacks
11:14AM  Omnicell's Global Expansion on Track, Stiff Competition Ails Zacks
09:30AM  Is ABIOMED (ABMD) Outperforming Other Medical Stocks This Year? Zacks
08:51AM  BioScrip (BIOS) Reports Loss in Q4, Both Margins Contract Zacks
07:00AM  Impella RP Post-Approval Study Data Presented at ACC 2019 Business Wire
Mar-15-19 03:26PM  Stryker Buys Israel-Based OrthoSpace, Strengthens MedSurg Zacks
11:01AM  Integra's Duragen Secures Japanese Nod to Drive Global Growth Zacks
10:02AM  Abbott (ABT) Gets FDA Approval for Expanded Use of MitraClip Zacks
Mar-14-19 03:32PM  Allscripts Strengthens Strategic Relationship with Pulse8 Zacks
09:36AM  Tandem Diabetes (TNDM) Hits a 52-Week High on Solid Prospects Zacks
09:12AM  Cardiovascular Systems Gains on Global Growth & Innovation Zacks
08:00AM  Benefits of Heart Recovery with Impella Showcased at ACC 2019 Business Wire
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella CP, a device used by interventional cardiologists to support patients in the cath lab and cardiac surgeons in the heart surgery suite. It also provides Impella 5.0 and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; and Impella RP, a percutaneous catheter-based axial flow pump. In addition, the company engages in the development of Impella 5.5 and Impella BTR that are percutaneous micro heart pumps with integrated motors and sensors; and Impella ECP pump that is designed for blood flow of greater than three liters per minute. It sells its products through direct sales and clinical support personnel in the United States, Canada, Europe, and Asia. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SUTTER MARTIN PDirectorMay 08Option Exercise7.6712,00092,040192,550May 10 04:10 PM
SUTTER MARTIN PDirectorMay 08Sale259.974,6641,212,494187,886May 10 04:10 PM
SUTTER MARTIN PDirectorFeb 15Sale360.3110,0003,603,110180,491Feb 15 04:37 PM
SUTTER MARTIN PDirectorFeb 14Sale360.005,0001,800,000190,491Feb 15 04:37 PM
SUTTER MARTIN PDirectorFeb 13Sale360.005,0001,800,000195,491Feb 15 04:37 PM
SUTTER MARTIN PDirectorFeb 06Sale349.495,9852,091,670200,491Feb 06 05:24 PM
SUTTER MARTIN PDirectorFeb 05Sale350.054,0721,425,390206,476Feb 06 05:24 PM
SUTTER MARTIN PDirectorFeb 04Sale350.2819,9436,985,575210,548Feb 06 05:24 PM
Weber David MChief Operating OfficerJan 25Option Exercise22.7424,000545,660171,842Jan 29 05:31 PM
Weber David MChief Operating OfficerJan 25Sale351.4724,0008,435,192147,842Jan 29 05:31 PM
Howley Michael GVP, Global Sales & MarketingSep 25Option Exercise23.1510,000231,50060,492Sep 26 04:25 PM
Howley Michael GVP, Global Sales & MarketingSep 25Sale432.5010,0004,325,00050,492Sep 26 04:25 PM
Greenfield Andrew JVP Healthcare SolutionsSep 24Option Exercise21.555,000107,75048,954Sep 26 04:24 PM
Greenfield Andrew JVP Healthcare SolutionsSep 24Sale420.005,0002,100,00043,954Sep 26 04:24 PM
Weber David MChief Operating OfficerJul 30Option Exercise22.4411,000246,840167,124Aug 01 04:37 PM
Weber David MChief Operating OfficerJul 30Sale356.7719,2826,879,302147,842Aug 01 04:37 PM